Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

David Metcalfe has been awarded both the prestigious Syme Medal and the AOUK&I Trauma Research Prize 2019 in recognition of his DPhil work in musculoskeletal science.

Horizontal portrait of David Metcalfe

Both awards recognised David's work undertaken as part of his NDORMS DPhil which he completed at the University of Oxford earlier this year. David delivered a number of studies that used routinely collected healthcare data to help clinicians provide better care for older adults with hip fractures. This work found widespread variation and even systematic inequalities in terms of the operations being offered to patients with broken hips. It also showed that the Hip Fracture Best Practice Tariff in England – which pays hospitals a supplement for providing high quality healthcare – improved quality of care and outcomes for these patients.

"These awards are important because they recognise the huge potential of data already collected by the NHS to improve patient care," said David.

The Syme Medal is awarded annually by The Royal College of Surgeons of Edinburgh for doctoral research that is "likely to influence clinical practice". The AOUK&I Trauma Research Prize is open to all surgeons in training for papers focused on any aspect of musculoskeletal trauma. David's DPhil research was funded by an Oxford-UCB Prize Fellowship.

Similar stories

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.